CONTEXT: Commercial announcement of new applications of existing software from Clarify Health, delivering RWE software products for the pharma and biotech industries. IMPACT: Low READ TIME: 2 mins Quality Level Continue Reading
CONTEXT: More evidence of the increasing focus on RWE, with Aetion securing another significant round of funding. The company reports doubling of revenues last year and is planning to expand Continue Reading
CONTEXT: Brief update and short (2min) webcast from Dr Verstovsek on real-world survival data for patients with myelofibrosis taking ruxolitinib. Overall patients saw an increased survival benefit of 1 year Continue Reading
CONTEXT: Commercial announcement of a RWE tie-up between C-Path Institute and Tufts. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 5 1. “”This will significantly add Continue Reading
CONTEXT: A very brief update, but a potentially very important one. The FDA is convening the paediatric subcommittee to discuss how to effectively use PROs in oncology studies. We will Continue Reading
CONTEXT: Real-world study from Japan showing increased rates of pneumonitis with first-line pembrolizumab plus chemotherapy in patients with advanced NSCLC. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 Continue Reading
CONTEXT: The term “Synthetic data” may not fill you with confidence, but it’s a phrase we will be seeing a lot more of in the future as organisations explore how Continue Reading
CONTEXT: Let the computer clean up your database? Well, that sounds scarier than “Synthetic Data”, but this author remembers when we used to write things down in a 3-part NCR Continue Reading
CONTEXT: Despite the headline news that RWE shows no real improvement for mesothelioma patients, if you get down to the end of the article, there is promising news with the Continue Reading
CONTEXT: Increased backing for the post-COVID era decentralised clinical trials. Can’t help thinking that this feels like a dot com bubble that will burst when the first major safety concerns Continue Reading
